Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Provention Bio, Inc. | Chief Scientific Officer | Common Stock | 0 | $24.32 | Apr 27, 2023 | By Immunosoma LLC | |
Provention Bio, Inc. | Chief Scientific Officer | Common Stock | 0 | $24.32 | Apr 27, 2023 | By Trust | |
Provention Bio, Inc. | Chief Scientific Officer | Common Stock | 0 | $24.32 | Apr 27, 2023 | Direct | |
Provention Bio, Inc. | Chief Scientific Officer | Option to Purchase Common Stock | 0 | Apr 27, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
PRVB | Provention Bio, Inc. | Apr 27, 2023 | 9 | $0 | 4 | Apr 27, 2023 | Chief Scientific Officer |
PRVB | Provention Bio, Inc. | Apr 13, 2023 | 2 | $0 | 4 | Apr 14, 2023 | Chief Scientific Officer |
PRVB | Provention Bio, Inc. | Feb 10, 2023 | 6 | -$577K | 4 | Feb 14, 2023 | Chief Scientific Officer |
PRVB | Provention Bio, Inc. | Jan 18, 2023 | 3 | -$187K | 4 | Jan 20, 2023 | Chief Scientific Officer |
PRVB | Provention Bio, Inc. | Jan 10, 2023 | 1 | $0 | 4 | Jan 11, 2023 | Chief Scientific Officer |
PRVB | Provention Bio, Inc. | Dec 29, 2022 | 3 | -$1.45M | 4 | Dec 30, 2022 | Chief Scientific Officer |
PRVB | Provention Bio, Inc. | Dec 27, 2022 | 3 | -$80.1K | 4 | Dec 29, 2022 | Chief Scientific Officer |
PRVB | Provention Bio, Inc. | Dec 22, 2022 | 6 | -$14.6K | 4 | Dec 27, 2022 | Chief Scientific Officer |
PRVB | Provention Bio, Inc. | Dec 8, 2022 | 1 | $0 | 4 | Dec 9, 2022 | Chief Scientific Officer |
PRVB | Provention Bio, Inc. | Nov 22, 2022 | 1 | $0 | 4 | Nov 23, 2022 | Chief Scientific Officer |
PRVB | Provention Bio, Inc. | Jan 18, 2022 | 1 | $0 | 4 | Jan 20, 2022 | Chief Scientific Officer |
PRVB | Provention Bio, Inc. | Dec 31, 2021 | 2 | $0 | 5 | Feb 14, 2022 | Chief Scientific Officer |
PRVB | Provention Bio, Inc. | Nov 24, 2021 | 1 | $40.2K | 4 | Nov 29, 2021 | Chief Scientific Officer |
PRVB | Provention Bio, Inc. | May 12, 2021 | 1 | $0 | 4 | May 14, 2021 | Chief Scientific Officer |